日本新薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/05/21 | 3,685 | 3,707 | 3,632 | 3,634 | -59 | -1.6% | 429,400 |
| 2024/05/20 | 3,657 | 3,727 | 3,645 | 3,693 | -5 | -0.1% | 422,200 |
| 2024/05/17 | 3,650 | 3,719 | 3,626 | 3,698 | +23 | +0.6% | 511,000 |
| 2024/05/16 | 3,714 | 3,716 | 3,629 | 3,675 | -55 | -1.5% | 688,700 |
| 2024/05/15 | 3,900 | 3,912 | 3,718 | 3,730 | -150 | -3.9% | 896,200 |
| 2024/05/14 | 3,893 | 3,923 | 3,873 | 3,880 | -13 | -0.3% | 502,400 |
| 2024/05/13 | 3,981 | 4,024 | 3,864 | 3,893 | -530 | -12% | 1,076,000 |
| 2024/05/10 | 4,458 | 4,475 | 4,404 | 4,423 | +10 | +0.2% | 270,000 |
| 2024/05/09 | 4,383 | 4,460 | 4,378 | 4,413 | ±0 | ±0% | 247,900 |
| 2024/05/08 | 4,400 | 4,439 | 4,373 | 4,413 | +27 | +0.6% | 272,100 |
| 2024/05/07 | 4,423 | 4,460 | 4,385 | 4,386 | -3 | -0.1% | 270,300 |
| 2024/05/02 | 4,455 | 4,468 | 4,345 | 4,389 | -28 | -0.6% | 435,400 |
| 2024/05/01 | 4,384 | 4,455 | 4,376 | 4,417 | +53 | +1.2% | 199,300 |
| 2024/04/30 | 4,351 | 4,369 | 4,305 | 4,364 | +29 | +0.7% | 195,800 |
| 2024/04/26 | 4,271 | 4,348 | 4,240 | 4,335 | +28 | +0.7% | 176,200 |
| 2024/04/25 | 4,320 | 4,351 | 4,300 | 4,307 | +11 | +0.3% | 170,400 |
| 2024/04/24 | 4,327 | 4,343 | 4,296 | 4,296 | +1 | ±0% | 209,600 |
| 2024/04/23 | 4,288 | 4,330 | 4,269 | 4,295 | +7 | +0.2% | 159,000 |
| 2024/04/22 | 4,257 | 4,295 | 4,235 | 4,288 | +83 | +2% | 225,000 |
| 2024/04/19 | 4,240 | 4,249 | 4,182 | 4,205 | -39 | -0.9% | 230,400 |
| 2024/04/18 | 4,275 | 4,301 | 4,243 | 4,244 | -41 | -1% | 234,500 |
| 2024/04/17 | 4,335 | 4,339 | 4,272 | 4,285 | -51 | -1.2% | 209,000 |
| 2024/04/16 | 4,263 | 4,340 | 4,240 | 4,336 | +56 | +1.3% | 225,900 |
| 2024/04/15 | 4,300 | 4,311 | 4,263 | 4,280 | -59 | -1.4% | 170,700 |
| 2024/04/12 | 4,247 | 4,341 | 4,245 | 4,339 | +84 | +2% | 278,100 |
| 2024/04/11 | 4,326 | 4,326 | 4,247 | 4,255 | -79 | -1.8% | 413,100 |
| 2024/04/10 | 4,322 | 4,372 | 4,321 | 4,334 | -2 | ±0% | 136,700 |
| 2024/04/09 | 4,341 | 4,363 | 4,297 | 4,336 | -26 | -0.6% | 221,800 |
| 2024/04/08 | 4,375 | 4,378 | 4,339 | 4,362 | -10 | -0.2% | 167,700 |
| 2024/04/05 | 4,311 | 4,372 | 4,300 | 4,372 | +40 | +0.9% | 306,800 |
| 2024/04/04 | 4,333 | 4,348 | 4,302 | 4,332 | +14 | +0.3% | 247,900 |
| 2024/04/03 | 4,301 | 4,353 | 4,267 | 4,318 | +3 | +0.1% | 354,600 |
| 2024/04/02 | 4,397 | 4,402 | 4,287 | 4,315 | -102 | -2.3% | 465,200 |
| 2024/04/01 | 4,480 | 4,484 | 4,415 | 4,417 | -53 | -1.2% | 260,200 |
| 2024/03/29 | 4,480 | 4,490 | 4,455 | 4,470 | -17 | -0.4% | 267,400 |
| 2024/03/28 | 4,589 | 4,598 | 4,445 | 4,487 | -137 | -3% | 396,300 |
| 2024/03/27 | 4,599 | 4,625 | 4,574 | 4,624 | +51 | +1.1% | 333,800 |
| 2024/03/26 | 4,560 | 4,580 | 4,514 | 4,573 | +6 | +0.1% | 204,000 |
| 2024/03/25 | 4,662 | 4,677 | 4,567 | 4,567 | -89 | -1.9% | 246,800 |
| 2024/03/22 | 4,660 | 4,684 | 4,615 | 4,656 | -15 | -0.3% | 295,800 |
| 2024/03/21 | 4,650 | 4,685 | 4,620 | 4,671 | +56 | +1.2% | 357,300 |
| 2024/03/19 | 4,580 | 4,615 | 4,563 | 4,615 | -6 | -0.1% | 367,100 |
| 2024/03/18 | 4,524 | 4,625 | 4,513 | 4,621 | +100 | +2.2% | 321,100 |
| 2024/03/15 | 4,501 | 4,536 | 4,481 | 4,521 | +1 | ±0% | 269,100 |
| 2024/03/14 | 4,492 | 4,520 | 4,438 | 4,520 | +28 | +0.6% | 266,300 |
| 2024/03/13 | 4,514 | 4,541 | 4,464 | 4,492 | -51 | -1.1% | 300,400 |
| 2024/03/12 | 4,579 | 4,580 | 4,444 | 4,543 | -13 | -0.3% | 303,900 |
| 2024/03/11 | 4,533 | 4,581 | 4,482 | 4,556 | +36 | +0.8% | 418,300 |
| 2024/03/08 | 4,424 | 4,525 | 4,350 | 4,520 | +26 | +0.6% | 548,500 |
| 2024/03/07 | 4,560 | 4,605 | 4,451 | 4,494 | -72 | -1.6% | 590,700 |
1～
50
件表示中 / 3459件
類似銘柄と比較する
現在ご覧いただいている「日本新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 日本新薬 | 363,400円 | +1.2% | -6.3% | 3.41% | 9.99倍 | 1.11倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| ツムラ | 392,900円 | +22.6% | +68.1% | 3.46% | 10.47倍 | 1.10倍 |
|
医療用漢方薬で国内シェア８割超。高齢者、がん支持療法、女性関連の３領域を重点に市場深耕 |
| サワイＧＨＤ | 611,500円 | +14.2% | +48.9% | 2.60% | 8.93倍 | 1.26倍 |
|
ジェネリック（後発）薬大手メーカー。２１年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
| ペプチド | 186,500円 | +56.7% | +357.2% | 0.00% | 17.27倍 | 5.99倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
| 科研薬 | 343,600円 | +4.2% | -21.6% | 4.37% | 23.24倍 | 0.91倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
市場注目の銘柄
チャート関連のコラム
